NASDAQ:DARE
Daré Bioscience, Inc. Stock News
$0.311
-0.0008 (-0.256%)
At Close: May 03, 2024
The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More
11:07am, Monday, 06'th Dec 2021 Benzinga
The omicron variant concerns were front and center in the markets in the week ended Dec. 3, and biotech stocks did not escape the brunt of selling in the wake of the negative development. The sector r
Dare Bioscience Stock (DARE): Why The Price Increased Today
06:48am, Monday, 06'th Dec 2021
The stock price of Daré Bioscience Inc (NASDAQ: DARE) increased by over 3% pre-market today. This is why it happened.
Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates
05:02pm, Thursday, 02'nd Dec 2021 Benzinga
A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for the year-to-date peri
3 Reddit Penny Stocks For Your Early December Watchlist
09:40pm, Tuesday, 30'th Nov 2021 PennyStocks
Check these Reddit penny stocks out for your December 2021 watchlist
The post 3 Reddit Penny Stocks For Your Early December Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information
3 Reddit Penny Stocks For Your Early December Watchlist
04:40pm, Tuesday, 30'th Nov 2021
Check these Reddit penny stocks out for your December 2021 watchlist The post 3 Reddit Penny Stocks For Your Early December Watchlist appeared first on Penny Stocks to Buy, Picks, News and Information
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2021 Results - Earnings Call Transcript
09:22pm, Wednesday, 10'th Nov 2021
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q3 2021 Results - Earnings Call Transcript
Dare Bioscience, Inc. (DARE) Reports Q3 Loss, Lags Revenue Estimates
10:43am, Wednesday, 10'th Nov 2021
Dare Bioscience, Inc. (DARE) delivered earnings and revenue surprises of -63.64% and -100.00%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the
Daré Bioscience to Participate in Panel Discussion at DTC Perspectives' Xpectives.Health Summit, October 12-14, 2021
08:51am, Wednesday, 06'th Oct 2021
An interactive conversation regarding the importance of industry and investor commitment to women's health innovation An interactive conversation regarding the importance of industry and investor comm
Daré Bioscience Announces NIH Grant Award to Support Development of DARE-LARC1
08:00am, Monday, 27'th Sep 2021
DARE-LARC1 Aims to Combine the Benefits of Long-acting Reversible Contraception with User-Controlled Flexibility to Pause or Resume Contraception as Desired DARE-LARC1 Aims to Combine the Benefits of
Daré Bioscience to Present at the 2021 Cantor Virtual Global Healthcare Conference
08:00am, Wednesday, 22'nd Sep 2021
SAN DIEGO, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced that Sabrina Martucci Johnson, its President and Chief Execu
Best Penny Stocks To Buy Now? 3 To Watch As AMC Stock Sparks Rally
03:31pm, Tuesday, 24'th Aug 2021
AMC stock spikes again, leaving penny stocks rallying in its wake The post Best Penny Stocks To Buy Now? 3 To Watch As AMC Stock Sparks Rally appeared first on Penny Stocks to Buy, Picks, News and Inf
Hot Penny Stocks to Watch Right Now, Have You Heard of These 3?
05:15pm, Thursday, 19'th Aug 2021
Are these penny stocks on your watchlist in August 2021? The post Hot Penny Stocks to Watch Right Now, Have You Heard of These 3?
3 Penny Stocks on Reddit That Traders Are Buying Right Now
11:15am, Sunday, 15'th Aug 2021
Reddit penny stocks are popular right now, here's 3 to watch The post 3 Penny Stocks on Reddit That Traders Are Buying Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | Pe
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q2 2021 Results - Earnings Call Transcript
07:31am, Friday, 13'th Aug 2021
Daré Bioscience, Inc. (DARE) CEO Sabrina Martucci Johnson on Q2 2021 Results - Earnings Call Transcript
Daré Bioscience Stock Is Trading Higher As Bacterial Vaginosis Candidate Secures FDA Priority Review
11:21am, Monday, 09'th Aug 2021
The FDA has accepted for review Daré Bioscience Inc's (NASDAQ: DARE) marketing application for DARE-BV1 for bacterial vaginosis. Under the priority review, the target goal date is December 7.
